Therapy-related MDS: The importance of repeating cytogenetics and immunophenotyping in "relapsed" AML

Journal of Hematopathology

Volumn 6, Issue 4, 2013, Pages 207-211

  Sharma, Prashant ^a   Kumar, Meet ^b   Lall, Meena ^c   Kumar, Lalit ^d   Bhargava, Manorama ^c  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b NRS MEDICAL COLLEGE   (India)

^c SIR GANGA RAM HOSPITAL   (India)

^d INSTITUTE ROTARY CANCER HOSPITAL   (India)

Author keywords

Acute myeloid leukaemia; Cytogenetic analysis; Flow cytometric immunophenotyping; Late complications; Secondary malignancy; Therapy related myelodysplastic syndromes

Indexed keywords

EID: 84888228772     PISSN: None     EISSN: 18655785     Source Type: Journal    
DOI: 10.1007/s12308-013-0178-8     Document Type: Article

References (16)

1. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (2008) WHO classification of tumours of haematopoietic and lymphoid tissues 4th edn. IARC, Lyon.
2. Tyagi S, Sharma P (2009) Secondary Leukaemias. In: Choudhry VP, Saxena R, Pati HP (eds) Recent Advances in Hematology, 3rd edn. Jaypee Brothers Medical Publishers, New Delhi, pp 211-225.
3. Nardi V, Winkfield KM, Ok CY, Niemierko A, Kluk MJ, Attar EC, Garcia-Manero G, Wang SA, Hasserjian RP (2012) Acute myeloid leukemia and myelodysplastic syndromes after radiation therapy are similar to de novo disease and differ from other therapy-related myeloid neoplasms. J Clin Oncol 30: 2340-2347.
4. Larson RA (2012) Cytogenetics, not just previous therapy, determines the course of therapy-related myeloid neoplasms. J Clin Oncol 30: 2300-2302.
5. Smith SM, Le Beau MM, Huo D, Karrison T, Sobecks RM, Anastasi J, Vardiman JW, Rowley JD, Larson RA (2003) Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series. Blood 102: 43-52.
6. Kern W, Haferlach T, Schnittger S, Ludwig WD, Hiddemann W, Schoch C (2002) Karyotype instability between diagnosis and relapse in 117 patients with acute myeloid leukemia: implications for resistance against therapy. Leukemia 16: 2084-2091.
7. Grimwade D, Hills RK, Moorman AV, Walker H, Chatters S, Goldstone AH, Wheatley K, Harrison CJ, Burnett AK (2010) National Cancer Research Institute Adult Leukaemia Working Group. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood 116(3): 354-365.
8. Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Solé F, Bennett JM, Bowen D, Fenaux P, Dreyfus F, Kantarjian H, Kuendgen A, Levis A, Malcovati L, Cazzola M, Cermak J, Fonatsch C, Le Beau MM, Slovak ML, Krieger O, Luebbert M, Maciejewski J, Magalhaes SM, Miyazaki Y, Pfeilstöcker M, Sekeres M, Sperr WR, Stauder R, Tauro S, Valent P, Vallespi T, van de Loosdrecht AA, Germing U, Haase D (2012) Revised international prognostic scoring system for myelodysplastic syndromes. Blood 120(12): 2454-2465.
9. Singh ZN, Huo D, Anastasi J, Smith SM, Karrison T, Le Beau MM, Larson RA, Vardiman JW (2007) Therapy-related myelodysplastic syndrome: morphologic subclassification may not be clinically relevant. Am J Clin Pathol 127: 197-205.
10. Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, Harris NL, Le Beau MM, Hellström-Lindberg E, Tefferi A, Bloomfield CD (2009) The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 114: 937-951.
11. Andersen MK, Larson RA, Mauritzson N, Schnittger S, Jhanwar SC, Pedersen-Bjergaard J (2002) Balanced chromosome abnormalities inv(16) and t(15;17) in therapy-related myelodysplastic syndromes and acute leukemia: report from an international workshop. Genes Chromosomes Cancer 33: 395-400.
12. Rowley JD, Olney HJ (2002) International workshop on the relationship of prior therapy to balanced chromosome aberrations in therapy-related myelodysplastic syndromes and acute leukemia: overview report. Genes Chromosomes Cancer 33: 331-345.
13. Garson OM, Hagemeijer A, Sakurai M, Reeves BR, Swansbury GJ, Williams GJ, Alimena G, Arthur DC, Berger R, de la Chapelle A et al (1989) Cytogenetic studies of 103 patients with acute myelogenous leukemia in relapse. Cancer Genet Cytogenet 40: 187-202.
14. Estey E, Keating MJ, Stass S (1995) Change in karyotype between diagnosis and first relapse in acute myelogenous leukemia. Leukemia 9: 972-976.
15. Ludwig WD, Haferlach T, Schoch C (2003) Classification of Acute Leukemias (Perspective 1). In: Pui CH (ed) Treatment of Acute Leukemias: New Directions for Clinical Research. Humana Press, Totowa, New Jersey, USA, pp 3-41.
16. Storlazzi CT, Anelli L, Albano F, Zagaria A, Ventura M, Rocchi M, Panagopoulos I, Pannunzio A, Ottaviani E, Liso V, Specchia G (2004) A novel chromosomal translocation t(3;7)(q26;q21) in myeloid leukemia resulting in overexpression of EVI1. Ann Hematol 83: 78-83.